Stockreport

Outlook advancing eye disease candidate ONS-5010 [Seeking Alpha]

Outlook Therapeutics, Inc.  (OTLK) 
Last outlook therapeutics, inc. earnings: 2/14 08:00 am Check Earnings Report
PDF Outlook advancing eye disease candidate ONS-5010 Outlook Therapeutics ( OTLK -4.5% filed an IND The U.S. portion, part of a second Phase 3 that includes sites in Austral [Read more]